Reversal of anticancer multidrug resistance by the ardeemins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 14, 1998, Pages 8369-8374

  Chou, Ting Chao ^a   Depew, Kristopher M ^a   Zheng, Y U Huang ^a   Safer, Michelle L ^a   Chan, Daniel ^b   Helfrich, Barbara ^b   Zatorska, Danuta ^a   Zatorski, Andrzej ^a   Bornmann, William ^a   Danishefsky, Samuel J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 N ACETYL 8 DEMETHYLARDEEMIN; 5 N ACETYLARDEEMIN DERIVATIVE; AZIDOPINE; DOXORUBICIN; GLYCOPROTEIN P; HEXAHYDROPYRROLOINDOLE; INDOLE ALKALOID; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PHOTOAFFINITY LABELING; PRIORITY JOURNAL;

ALKALOIDS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, LYMPHOCYTIC; MICE; PYRIMIDINONES; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0013603199     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.14.8369     Document Type: Article

References (30)

1. Laing, N. M. & Tew, K. D. (1997) in Encyclopedia of Cancer, ed. Bertino, J. R. (Academic, San Diego), Vol. 1, pp. 560-570.
2. Gottesman, M. M. & Pastan, I. (1993) Annu. Rev. Biochem. 62, 385-427.
3. Fan, D., Beltran, P. J. & O'Brian, C. A. (1994) in Reversal of Multidrug Resistance in Cancer, ed. Kellen, J. A. (CRC, Boca Raton, FL), pp. 93-125.
4. Pirker, R., Zochbauer, S., Kupper, H., Lassmann, A., Gsur, A., Frass, M., Krajnik, G., Knobl, P. & Lechner, A. (1991) Eur. J. Cancer 27, 1639-1642.
5. Pirker, R., Keilhauer, G., Raschack, M., Lechner, C. & Ludwig, H. (1989) Int. J. Cancer 45, 916-919.
6. Ross, D. D., Wooten, P. J., Sidhara, R., Ordonez, J. V., Lee, E. J. & Schiffer, C. A. (1994) Blood 82, 1288-1299.
7. Malayeri, R., Filipits, M., Suchomel, R. W., Zochbauer, S., Lechner, K. & Pirker, R. (1996) Leukemia Lymphoma 23, 451-458.
8. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. V., Duncan, A. M. V. & Deeley, R. G. (1992) Science 258, 1650-1654.
9. Scheffer, G. L., Wijngaard, P. L. J., Flens, M. J., Inzquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C. J. L. M., Clevers, H. C. & Scheper, R. J. (1995) Nat. Med. 1, 578-582.
10. Beck, W. T. (1989) J. Natl. Cancer Inst. 81, 1683-1685.
11. Slate, L. D., Bruno, A. N., Casey, M. S., Zutshi, N., Garvin, J. L., Wu, H. & Pfister, R. J. (1995) Anticancer Res. 15, 811-814.
12. Karnowski, J. P., Jackson, M., Rasmussen, R. R., Humphrey, P. E., Poddig, J. B., Kohl, W. L., Scherr, M. H., Kadam, S. & McAlpine, J. B. (1993) J. Antibiot. 46, 374-386.
13. Marsden, S. P., Depew, K. M. & Danishefsky, S. J. (1994) J. Am. Chem. Soc. 116, 11143-11144.
14. Beck, W. T., Mueller, T. J. & Tanzer, L. R. (1979) Cancer Res. 39, 2027-2076.
15. Fisher, E. R. & Faulson, J. D. (1978) Cancer Res. 38, 3830-38356.
16. Koros, A. M., Klein, E. C., Pan, S., Atchison, R. W., Lakomy, R., Bahnson, A. & Shever, C. (1985) Cancer Res. 45, 2725-2731.
17. Chan, D., Chuang, N., Jewett, P., Kirpotin, D., Helfrich, B. & Bunn, P., Jr. (1993) Proc. Am. Assoc. Cancer Res. 34, 323 (Abstr.)
18. Chan, D., Helfrich, B., Helm, K., Chou, T. & Bunn, P. (1997) Proc. Am. Assoc. Cancer Res. 38, 591 (Abstr.).
19. Keizer, H., Schuurhuis, G. J., Broxterman, H. J., Lankelma, J., Schounen, W., Vani Rijin, J., Pinedo, H. M. & Joenje, H. (1989) Cancer Res. 49, 2988-2993.
20. Kuiper, C. M., Broxterman, H. J., Baas, F., Schuurhuis, G. J., Haisma, H. J., Scheffer, G. L., Lankelma, J. & Pinedo, H. M. (1990) J. Cell Pharmacol. 1, 35-41.
21. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. & Boyd, M. R. (1988) Cancer Res. 48, 4827-4833.
22. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S. & Boyd, M. R. (1990) J. Natl. Cancer Inst. 82, 1107-1112.
23. Chou, J. & Chou, T.-C. (1987) Dose-Effect Analysis with Microcomputers: Quantitation of ED 50, Synergism, Antagonism, Low-Dose Risk, Reception-Ligand Binding and Enzyme Kinetics (Biosoft, Cambridge, U.K.).
24. Chou, T.-C. & Hayball, M. (1996) CalcuSyn for Windows 3.1 and Windows 95: Multiple Drug Dose-Effect Analyzer and Manual for IBM-PC (Biosoft, Cambridge, U.K.).
25. Gerlach, J. H., Bell, D. R., Karakousis, C., Slocum, H. K., Kartner, N., Rustum, Y. M., Ling, V. & Baker, R. M. (1987) J. Clin. Oncol. 5, 1452-1460.
26. Zhang, L., Sachs, C. W., Fine, R. L. & Casey, P. J. (1994) J. Biol. Chem. 269, 15973-15976.
27. Wohlhueter, R. M., Marz, R., Graff, J. C. & Plagemann, R. G. W. (1978) Methods Cell Biol. 20, 211-236.
28. Kolassa, N., Paterson, A. R. P. & Chou, T.-C. (1983) Cancer Treatment Ref. 67, 51-58.
29. Chou, T.-C. & Talalay, P. T. (1984) Adv. Enzyme Regul. 22, 27-55.
30. Chou, T. C. (1991) in Synergism and Antagonism in Chemotherapy, eds. Chou, T.-C. & Rideout, D. C. (Academic, San Diego), pp. 61-102.